The FDA informed Intercept that it is unable to approve the sNDA in its current form, consistent with the outcome of the Gastrointestinal Drugs Advisory Committee (GIDAC) meeting in September 2024. In ...
There is fresh hope for patients with a rare, deadly form of cancer most commonly found in younger adults. Some Albertans are part of the fight for approval of a promising new treatment. Golfing and ...
Pancreaticobiliary cytopathology has emerged as a critical diagnostic tool, especially in evaluating pancreatic and bile duct lesions. Traditionally ...